Breaking News Bar

Business News and Information

Kymera extends growth with $2.1B Sanofi deal

French drug giant Sanofi has evolved from one of Kymera Therapeutics Inc.’s investors to a development partner.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear